Fusion event
HBV-OR2L13 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
AGAAGATTGCAATTGATTATGCCTGCCAGGTTTTATCCAAAGGTTACCAAATATTTACCATTGGATAAGGGTATTAAACCTTATTATCCAGAACATCTAG| |TTAATCATTACTTCCAAACTAGACACTATTTACACACTCTATGGAAGGCGGGTATATTATATAAGAGAGAAACAACACATAGCGCCTCATTTTGTGGGTC
End
248194670/248031368 (Hg38)
Nearest miRNA
hsa-mir-101-1/Upstream/829308; hsa-mir-3124/Downstream/795009;
Upstream sequence
GAATTAGAGCCTTGGAACATGAATAATCAAAGAGATGCTACATTGGTGTTCATGAGATATtgtaacatcgcagaacacatctcctgcccctcagcacttg
Downstream sequence
taaagtcctgttaacaagagcaaggtctggtagaaagaaagactttttcttccaagcttagctgaggggaagcaggacaggcttctgccttaatgggcag
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.